Home/ Deals/ Bio-Rad Laboratories / Stilla Technologies
Verified Healthcare Acquisition 30 Jun 2025

Bio-Rad Laboratories acquires Stilla Technologies
for $275m

Bio-Rad Laboratories → Stilla Technologies · Healthcare · Acquisition

Close date30 Jun 2025
Announced13 Feb 2025
Deal value$275m
Quality score99%
Acquirer HQ🇺🇸
Target HQ🇫🇷
AI-generated analysis

Bio-Rad Laboratories acquired Stilla Technologies to expand its diagnostic capabilities.

◆ Generated by Claude (Anthropic) · Not investment advice · Methodology →

Sources & verification

1
Crosstree
crosstreecapital.com
Press
2
investors.bio-rad.com
investors.bio-rad.com
Press
3
Business Wire
businesswire.com
Wire
4
bio-rad.com
bio-rad.com
Press
5
Biospace
biospace.com
Press
6
Kurma Partners
kurmapartners.com
Press

Verification quality score: 99%

Source count
1.00
Field completeness
0.93
AI confidence
1.00
Date plausibility
1.00
Value plausibility
1.00
Entity quality
1.00
See an error? Submit a correction → · All corrections reviewed within 24 hours.
Key facts
SectorHealthcare
Deal typeAcquisition
Value$275m
Close date30 Jun 2025
Announced13 Feb 2025
Quality score99%
Acquirer HQ🇺🇸
Target HQ🇫🇷
Export this deal
Related deals